BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kocoglu H, Velibeyoglu FM, Karaca M, Tural D. Clinical efficacy and drug resistance of anti-epidermal growth factor receptor therapy in colorectal cancer. World J Gastrointest Oncol 2016; 8(1): 1-7 [PMID: 26798432 DOI: 10.4251/wjgo.v8.i1.1]
URL: https://www.wjgnet.com/1948-5204/full/v8/i1/1.htm
Number Citing Articles
1
Peng Ye, Yiran Wang, Ruiqi Li, Wanlu Chen, Lu Wan, Peiling Cai. The HER family as therapeutic targets in colorectal cancerCritical Reviews in Oncology/Hematology 2022; 174: 103681 doi: 10.1016/j.critrevonc.2022.103681
2
Anna M. Valentini, Elisabetta Cavalcanti, Marianna Di Maggio, Maria L. Caruso. RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision MedicineApplied Immunohistochemistry & Molecular Morphology 2018; 26(8): 539 doi: 10.1097/PAI.0000000000000475
3
Laura M. López‐Sánchez, Rafael Jiménez‐Izquierdo, Jon Peñarando, Rafael Mena, Silvia Guil‐Luna, Marta Toledano, Francisco Conde, Carlos Villar, César Díaz, Ignacio Ortea, Juan R. De la Haba‐Rodríguez, Enrique Aranda, Antonio Rodríguez‐Ariza. SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumoursJournal of Cellular and Molecular Medicine 2019; 23(12): 8219 doi: 10.1111/jcmm.14693